Drugs / Allegra-D
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00562120 Comparator | Dec 2007 → Aug 2008 | allergic rhinitis | Pfizer | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allegra-D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00562120 ↗ |
| Route | Oral | “A single oral dose of Allegra-D is dosed to subjects” NCT00562120 ↗ |